<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35545612</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes.</ArticleTitle><Pagination><StartPage>2592</StartPage><MedlinePgn>2592</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2592</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-30248-0</ELocationID><Abstract><AbstractText>Sequencing cases without matched healthy controls hinders prioritization of germline disease-predisposition genes. To circumvent this problem, genotype summary counts from public data sets can serve as controls. However, systematic inflation and false positives can arise if confounding factors are not controlled. We propose a framework, consistent summary counts based rare variant burden test (CoCoRV), to address these challenges. CoCoRV implements consistent variant quality control and filtering, ethnicity-stratified rare variant association test, accurate estimation of inflation factors, powerful FDR control, and detection of rare variant pairs in high linkage disequilibrium. When we applied CoCoRV to pediatric cancer cohorts, the top genes identified were cancer-predisposition genes. We also applied CoCoRV to identify disease-predisposition genes in adult brain tumors and amyotrophic lateral sclerosis. Given that potential confounding factors were well controlled after applying the framework, CoCoRV provides a cost-effective solution to prioritizing disease-risk genes enriched with rare pathogenic variants.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-0379-2368</Identifier><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA. wenan.chen@stjude.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuoguo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>150 Second Street, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tithi</LastName><ForeName>Saima Sultana</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Cell &amp; Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellison</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaid</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1678-5864</Identifier><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA. gang.wu@stjude.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. gang.wu@stjude.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA021765</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM140487</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35545612</ArticleId><ArticleId IdType="pmc">PMC9095601</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30248-0</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-30248-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnowski C, et al. Impact of rare and common genetic variants on diabetes diagnosis by hemoglobin A1c in multi-ancestry cohorts: the Trans-Omics for Precision Medicine Program. Am. J. Hum. Genet. 2019;105:706&#x2013;718. doi: 10.1016/j.ajhg.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2019.08.010</ArticleId><ArticleId IdType="pmc">PMC6817529</ArticleId><ArticleId IdType="pubmed">31564435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheway G, Mitchison HM, Genomics England Research C. Opportunities and challenges for molecular understanding of ciliopathies&#x2014;the 100,000 Genomes Project. Front. Genet. 2019;10:127. doi: 10.3389/fgene.2019.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00127</ArticleId><ArticleId IdType="pmc">PMC6421331</ArticleId><ArticleId IdType="pubmed">30915099</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo MH, Plummer L, Chan YM, Hirschhorn JN, Lippincott MF. Burden testing of rare variants identified through exome sequencing via publicly available control data. Am. J. Hum. Genet. 2018;103:522&#x2013;534. doi: 10.1016/j.ajhg.2018.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2018.08.016</ArticleId><ArticleId IdType="pmc">PMC6174288</ArticleId><ArticleId IdType="pubmed">30269813</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KL, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173:355&#x2013;370 e314. doi: 10.1016/j.cell.2018.03.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.039</ArticleId><ArticleId IdType="pmc">PMC5949147</ArticleId><ArticleId IdType="pubmed">29625052</ArticleId></ArticleIdList></Reference><Reference><Citation>Waszak SM, et al. Germline Elongator mutations in Sonic Hedgehog medulloblastoma. Nature. 2020;580:396&#x2013;401. doi: 10.1038/s41586-020-2164-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2164-5</ArticleId><ArticleId IdType="pmc">PMC7430762</ArticleId><ArticleId IdType="pubmed">32296180</ArticleId></ArticleIdList></Reference><Reference><Citation>Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Preprint at https://www.biorxiv.org/content/10.1101/201178v3 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/201178v3</ArticleId></ArticleIdList></Reference><Reference><Citation>Price AL, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006;38:904&#x2013;909. doi: 10.1038/ng1847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1847</ArticleId><ArticleId IdType="pubmed">16862161</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>D&#xf6;hler S, Durand G, Roquain E. New FDR bounds for discrete and heterogeneous tests. Electron. J. Stat. 2018;12:1867&#x2013;1900. doi: 10.1214/18-EJS1441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/18-EJS1441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. doi: 10.1093/nar/gkq603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq603</ArticleId><ArticleId IdType="pmc">PMC2938201</ArticleId><ArticleId IdType="pubmed">20601685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis NM, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 2016;99:877&#x2013;885. doi: 10.1016/j.ajhg.2016.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.08.016</ArticleId><ArticleId IdType="pmc">PMC5065685</ArticleId><ArticleId IdType="pubmed">27666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton D, Leung HT. An R package for analysis of whole-genome association studies. Hum. Hered. 2007;64:45&#x2013;51. doi: 10.1159/000101422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000101422</ArticleId><ArticleId IdType="pubmed">17483596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes. Nat. Commun. 2020;11:2539. doi: 10.1038/s41467-019-12438-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12438-5</ArticleId><ArticleId IdType="pmc">PMC7253413</ArticleId><ArticleId IdType="pubmed">32461613</ArticleId></ArticleIdList></Reference><Reference><Citation>Muskens IS, et al. Germline genetic landscape of pediatric central nervous system tumors. Neuro Oncol. 2019;21:1376&#x2013;1388. doi: 10.1093/neuonc/noz108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/noz108</ArticleId><ArticleId IdType="pmc">PMC6827836</ArticleId><ArticleId IdType="pubmed">31247102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendricks AE, et al. ProxECAT: proxy external controls association test. A new case-control gene region association test using allele frequencies from public controls. PLoS Genet. 2018;14:e1007591. doi: 10.1371/journal.pgen.1007591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007591</ArticleId><ArticleId IdType="pmc">PMC6191077</ArticleId><ArticleId IdType="pubmed">30325923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 2015;373:2336&#x2013;2346. doi: 10.1056/NEJMoa1508054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1508054</ArticleId><ArticleId IdType="pmc">PMC4734119</ArticleId><ArticleId IdType="pubmed">26580448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, H. M. EPACTS: efficient and parallelizable association container toolbox. http://genome.sph.umich.edu/wiki/EPACTS (2019).</Citation></Reference><Reference><Citation>Guha, T. &amp; Malkin, D. Inherited TP53 mutations and the Li-Fraumeni syndrome. Cold Spring Harb. Perspect. Med.7, 10.1101/cshperspect.a026187 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378014</ArticleId><ArticleId IdType="pubmed">28270529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sontheimer H. An unexpected role for ion channels in brain tumor metastasis. Exp. Biol. Med. 2008;233:779&#x2013;791. doi: 10.3181/0711-MR-308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0711-MR-308</ArticleId><ArticleId IdType="pmc">PMC2557067</ArticleId><ArticleId IdType="pubmed">18445774</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner KL, Sontheimer H. Cl- and K+ channels and their role in primary brain tumour biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014;369:20130095. doi: 10.1098/rstb.2013.0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2013.0095</ArticleId><ArticleId IdType="pmc">PMC3917349</ArticleId><ArticleId IdType="pubmed">24493743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard toolkit. https://broadinstitute.github.io/picard/ (Broad Institute, Broad Institute, GitHub repository, 2019).</Citation></Reference><Reference><Citation>Aschard H, Vilhjalmsson BJ, Joshi AD, Price AL, Kraft P. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am. J. Hum. Genet. 2015;96:329&#x2013;339. doi: 10.1016/j.ajhg.2014.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.12.021</ArticleId><ArticleId IdType="pmc">PMC4320269</ArticleId><ArticleId IdType="pubmed">25640676</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir, B. S. Genetic Data Analysis. 2nd edn. (Sinauer Associates, 1996).</Citation></Reference><Reference><Citation>Hui TJ, Burt A. Estimating linkage disequilibrium from genotypes under Hardy-Weinberg equilibrium. BMC Genet. 2020;21:21. doi: 10.1186/s12863-020-0818-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12863-020-0818-9</ArticleId><ArticleId IdType="pmc">PMC7045472</ArticleId><ArticleId IdType="pubmed">32102657</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaid DJ. Linkage disequilibrium testing when linkage phase is unknown. Genetics. 2004;166:505&#x2013;512. doi: 10.1534/genetics.166.1.505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.166.1.505</ArticleId><ArticleId IdType="pmc">PMC1470678</ArticleId><ArticleId IdType="pubmed">15020439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T, et al. Estimation of haplotype frequencies, linkage-disequilibrium measures, and combination of haplotype copies in each pool by use of pooled DNA data. Am. J. Hum. Genet. 2003;72:384&#x2013;398. doi: 10.1086/346116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/346116</ArticleId><ArticleId IdType="pmc">PMC379231</ArticleId><ArticleId IdType="pubmed">12533787</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, G. The NLopt nonlinear-optimization package. http://github.com/stevengj/nlopt.</Citation></Reference><Reference><Citation>Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. arXiv Prepr. 2012;1207:3907.</Citation></Reference><Reference><Citation>Regier AA, et al. Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects. Nat. Commun. 2018;9:4038. doi: 10.1038/s41467-018-06159-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06159-4</ArticleId><ArticleId IdType="pmc">PMC6168605</ArticleId><ArticleId IdType="pubmed">30279509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhakta N, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE) Lancet. 2017;390:2569&#x2013;2582. doi: 10.1016/S0140-6736(17)31610-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31610-0</ArticleId><ArticleId IdType="pmc">PMC5798235</ArticleId><ArticleId IdType="pubmed">28890157</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecham GW, et al. The Alzheimer&#x2019;s Disease Sequencing Project: Study design and sample selection. Neurol. Genet. 2017;3:e194. doi: 10.1212/NXG.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000194</ArticleId><ArticleId IdType="pmc">PMC5646177</ArticleId><ArticleId IdType="pubmed">29184913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairley S, Lowy-Gallego E, Perry E, Flicek P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Res. 2020;48:D941&#x2013;D947. doi: 10.1093/nar/gkz836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz836</ArticleId><ArticleId IdType="pmc">PMC6943028</ArticleId><ArticleId IdType="pubmed">31584097</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti, A. A. Categorical Data Analysis. 3rd edn (Wiley, 2012).</Citation></Reference><Reference><Citation>ZELEN M. The analysis of several 2&#x2009;&#xd7;&#x2009;2 contingency tables. Biometrika. 1971;58:129&#x2013;137.</Citation></Reference><Reference><Citation>Mehta CR, Patel NR, Gray R. Computing an exact confidence interval for the common odds ratio in several 2&#x2009;&#xd7;&#x2009;2 contingency tables. J. Am. Stat. Assoc. 1985;80:969&#x2013;973.</Citation></Reference><Reference><Citation>Yekutieli D, Benjamini Y. Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J. Stat. Plan. Inference. 1999;82:171&#x2013;196. doi: 10.1016/S0378-3758(99)00041-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-3758(99)00041-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini, Y., Kenigsberg, E., Reiner, A. &amp; Yekutieli, D. fdrame: FDR adjustments of microarray experiments (FDR-AME). (R package version 1.64.0., 2021).</Citation></Reference><Reference><Citation>D&#xf6;hler S, Durand G, Roquain E. New FDR bounds for discrete and heterogeneous tests. Electron. J. Stat. 2018;12:1867&#x2013;1900. doi: 10.1214/18-EJS1441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/18-EJS1441</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddelbuettel D, Francois R. Rcpp: seamless R and C plus plus Integration. J. Stat. Softw. 2011;40:1&#x2013;18.</Citation></Reference><Reference><Citation>CoCoRV: a rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes. 10.5281/zenodo.6416062 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9095601</ArticleId><ArticleId IdType="pubmed">35545612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>